Skip to main content
SpringerLink
Log in

Analysis of Prognostic Factors Affecting Survival After Initial Recurrence and Treatment Efficacy for Recurrence in Patients Undergoing Potentially Curative Hepatectomy for Hepatocellular Carcinoma

  • Hepatic and Pancreatic Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Survival analysis in patients with initial recurrence after curative hepatectomy for hepatocellular carcinoma (HCC) has not been well evaluated. In addition, selections of the most effective treatments for patients with recurrent HCC still remain controversial.

Methods

Three hundred and nineteen patients who underwent potentially curative hepatectomies were followed for initial recurrence, and factors predictive of recurrence were determined. The factors affecting survival including pattern of recurrence and treatment modalities from the time of initial recurrence in 211 patients were retrospectively analyzed.

Results

The overall 5-year disease-free survival rate of 319 patients was 31.1%. The 5-year survival rate of 211 patients from the time of initial recurrence was 31.9%. In a multivariate analysis, a low indocyanine green retention rate, lack of liver cirrhosis, a long interval before recurrence, the absence of portal vein invasion, and intrahepatic recurrence (≤3 nodules) were shown to be significantly favorable prognostic factors after the initial recurrence. The 5-year survival rate of patients with intrahepatic recurrence (≤3 nodules) was 42.3%, and no survival differences were observed among different treatment modalities.

Conclusion

When the initial recurrence occurred after a longer interval, and/or with three or fewer intrahepatic recurrent nodules, a favorable prognosis could be expected in those patients with better liver function and no portal vein invasion at the time of the primary hepatectomy. It is important to conduct a randomized controlled trial to clarify a method for selecting optimal treatment in patients with a smaller number of initial intrahepatic recurrences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1.
FIG. 2.
FIG.3. 
FIG. 4.
FIG. 5.

Similar content being viewed by others

Reference

  1. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 2000; 191:38–46

    Article  PubMed  CAS  Google Scholar 

  2. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002; 236:397–406

    Article  PubMed  Google Scholar 

  3. Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003; 138:1198–206

    Article  PubMed  Google Scholar 

  4. Takenaka K, Adachi E, Nishizaki T, et al. Possible multicentric occurrence of hepatocellular carcinoma: a clinicopathological study. Hepatology 1994; 19:889–94

    Article  PubMed  CAS  Google Scholar 

  5. Funaki NO, Tanaka J, Seto S, et al. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology 1997; 25:564–8

    Article  PubMed  CAS  Google Scholar 

  6. Okuda K. Early detection of hepatocellular carcinoma. Hepatology 1986; 6:729–38

    Article  PubMed  CAS  Google Scholar 

  7. Takayasu K, Furukawa H, Wakao F, et al. CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation. Am J Roentgenol 1995; 164:885–90

    CAS  Google Scholar 

  8. Takayama T, Makuuchi M, Hirohashi S, et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998; 28:1241–6

    Article  PubMed  CAS  Google Scholar 

  9. Nakajima Y, Ohmura T, Kimura J, et al. Role of surgical treatment for recurrent hepatocellular carcinoma after hepatic resection. World J Surg 1993; 17:792–5

    Article  PubMed  CAS  Google Scholar 

  10. Suenaga M, Sugiura H, Kokuba Y, et al. Repeated hepatic resection for recurrent hepatocellular carcinoma in eighteen cases. Surgery 1994; 115:452–7

    PubMed  CAS  Google Scholar 

  11. Hu RH, Lee PH, Yu SC, et al. Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors. Surgery 1996; 120:23–29

    Article  PubMed  CAS  Google Scholar 

  12. Shimada M, Takenaka K, Taguchi K, et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 1998; 227:80–5

    Article  PubMed  CAS  Google Scholar 

  13. Poon RTP, Fan ST, Lo CM, et al. Intrahepatic recurrence after curative recurrence of hepatocellular carcinoma: Long-term results of treatment and prognostic factors. Ann Surg 1999; 229:216–22

    Article  PubMed  CAS  Google Scholar 

  14. Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003; 238:703–10

    Article  PubMed  Google Scholar 

  15. Yamamoto J, Okada S, Shimada K, et al. Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001; 34:707–13

    Article  PubMed  CAS  Google Scholar 

  16. Taura K, Ikai I, Hatano E, Fujii H, Uyama N, Shimaharu Y. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection An analysis of 610 patients over 16 years old. Ann Surg 2006; 244:265–73

    Article  PubMed  Google Scholar 

  17. Lee PH, Lin WJ, Tsang YM, et al. Clinical management of recurrent hepatocellular carcinoma. Ann Surg 1995; 222:670–6

    Article  PubMed  CAS  Google Scholar 

  18. Takayasu K, Arii S, Ikai I, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006; 131:461–9

    Article  PubMed  CAS  Google Scholar 

  19. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 1996; 334:693–9

    Article  PubMed  CAS  Google Scholar 

  20. Todo S, Furukawa H. Living donor liver transplantation for adult patients with hepatocellular carcinoma Experience in Japan. Ann Surg 2004; 240:451–61

    Article  PubMed  Google Scholar 

  21. Arii S, Tanaka J, Yamazoe Y, et al. Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 1991; 69:913–9

    Article  Google Scholar 

  22. Nagasue N, Uchida M, Makino Y, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105:488–94

    PubMed  CAS  Google Scholar 

  23. Okada S, Shimada K, Yamamoto J, et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994; 106:1618–24

    PubMed  CAS  Google Scholar 

  24. Poon RTP, Ng IO, Fan ST, et al. Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: A study of a prospective cohort. J Clin Oncol 2001; 19:3037–44

    PubMed  CAS  Google Scholar 

  25. Portolani N, Coniglio A, Giovanelli M, et al. Early and late recurrence after resection for hepatocellular carcinoma Prognosis and therapeutic implications. Ann Surg 2006 243:229–35

    Article  PubMed  Google Scholar 

  26. Shimada M, Takenaka K, Gion T, et al. Prognosis of recurrent hepatocellular carcinoma: A 10-year surgical experience in Japan. Gastroenterology 1996; 111:720–6

    Article  PubMed  CAS  Google Scholar 

  27. Miyagawa M, Makuuchi M, Kawasaki S, et al. Criteria for safe hepatic resection. Am J Surg 1995; 169:589–94

    Article  PubMed  CAS  Google Scholar 

  28. Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 2nd ed. Tokyo: Kanehara, 2003

  29. Yamanaka N, Tanaka T, Tanaka W, et al. Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma. Cancer 1997; 79:1509–15

    Article  PubMed  CAS  Google Scholar 

  30. Shiratori Y, Shiina S, Teratani T, et al. Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Intern Med 2003; 138:299–306

    PubMed  Google Scholar 

  31. Park JH, Koh KC, Choi MS, et al. Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. Am J Surg 2006; 192:29–33

    Article  PubMed  Google Scholar 

  32. Sakon M, Nagano H, Dono K, et al. Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer 2002; 94:435–42

    Article  PubMed  CAS  Google Scholar 

  33. Ando E, Tanaka M, Yamashita F. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Cancer 2002; 95:588–95

    Article  PubMed  Google Scholar 

  34. Ryu M, Shimamura Y, Kinoshita T, et al. Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a prospective multicenter study. Jpn J Clin Oncol 1997; 27:251–7

    Article  PubMed  CAS  Google Scholar 

  35. Matsui O, Kadoya N, Yoshikawa J, et al. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 1993; 188:79–83

    PubMed  CAS  Google Scholar 

  36. Takayasu K, Muramatsu Y, Maeda T, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. Am J Roentgenol 2001; 176:681–8

    CAS  Google Scholar 

  37. Lau WY, Leung TWT, Yu SCH, Ho SKW. Percutaneous local ablate therapy for hepatocellular carcinoma A review and look into the future. Ann Surg 2003; 2:171–9

    Article  Google Scholar 

  38. Lau WY, Leung TW, Ho SK, et al. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial. Lancet 1999; 353:797–801

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This study was supported by a Grant-in-Aid for cancer research from the Ministry of Health, Welfare and Labor of Japan.

Author information

Authors and Affiliations

  1. Division of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo, Japan

    Kazuaki Shimada MD, Yoshihiro Sakamoto MD, Minoru Esaki MD, Tomoo Kosuge MD & Chigusa Morizane MD

  2. Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan

    Masafumi Ikeda MD, Hideki Ueno MD & Takuji Okusaka MD

  3. Division of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan

    Yasuaki Arai MD & Kenichi Takayasu MD

Authors
  1. Kazuaki Shimada MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshihiro Sakamoto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Minoru Esaki MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tomoo Kosuge MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chigusa Morizane MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masafumi Ikeda MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hideki Ueno MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Takuji Okusaka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yasuaki Arai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kenichi Takayasu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazuaki Shimada MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shimada, K., Sakamoto, Y., Esaki, M. et al. Analysis of Prognostic Factors Affecting Survival After Initial Recurrence and Treatment Efficacy for Recurrence in Patients Undergoing Potentially Curative Hepatectomy for Hepatocellular Carcinoma. Ann Surg Oncol 14, 2337–2347 (2007). https://doi.org/10.1245/s10434-007-9415-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9415-7

Keywords

Search

Navigation